An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer

Overview of attention for article published in Frontiers in Pharmacology, July 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 13 X posts from 13 X users, with an upper bound of 13,917 followers.

New article: An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer https://t.co/atIGtLJTwE #breastcancer #oncology https://t.co/hUUVS9yzgc

RT @LGerratana: How to integrate CDK4/6 inhibitors with a #personalized pharmacological approach in #BreastCancer patients. The key to #Pre…

RT @LGerratana: How to integrate CDK4/6 inhibitors with a #personalized pharmacological approach in #BreastCancer patients. The key to #Pre…

RT @LGerratana: How to integrate CDK4/6 inhibitors with a #personalized pharmacological approach in #BreastCancer patients. The key to #Pre…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.